跳至主要内容
临床试验/NL-OMON45383
NL-OMON45383招募中不适用

The effects of human endotoxemia on the functional capacity of hematopoietic stem and progenitor cells - LPS-BM study

Radboud Universitair Medisch Centrum0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Written informed consent
  • - Age >=18 and <=35 yrs
  • - Healthy (as confirmed by medical history, examination, ECG, blood sampling)

排除标准

  • Use of any medication
  • History or signs of atopic syndrome (asthma, rhinitis with medication and/or eczema)
  • Known anaphylaxis or hypersensitivity to the non-investigational products or their excipients.
  • History or signs of hematological disease (bone marrow dysfunction):
  • Thrombocytopenia (<150*10^9/ml) or anemia (hemoglobin < 8.0 mmol/L)
  • Abnormalities in leukocyte differential counts
  • History, signs or symptoms of cardiovascular disease, in particular:
  • Previous spontaneous vagal collapse
  • History of atrial or ventricular arrhythmia
  • Cardiac conduction abnormalities on the ECG consisting of a 2nd degree atrioventricular block or a complete left bundle branch block
  • Hypertension (defined as RR systolic > 160 or RR diastolic > 90)
  • Hypotension (defined as RR systolic < 100 or RR diastolic < 50)
  • Renal impairment (defined as plasma creatinine >120 µmol/l)
  • Liver enzyme abnormalities (above 2x the upper limit of normal)
  • Medical history of any disease associated with immune deficiency
  • CRP > 20 mg/L, WBC > 12x109/L or < 4 x109/L, or clinically significant acute illness, including infections, within 3 weeks before labeling day
  • Previous (participation in a study with) LPS administration
  • Any vaccination within 3 months prior to labeling day
  • Participation in a drug trial or donation of blood 3 months prior to labeling day
  • Recent hospital admission or surgery with general anesthesia (<3 months to labeling day)
  • Use of recreational drugs within 21 days prior to labeling day
  • Inability to personally provide written informed consent (e.g. for linguistic or mental reasons) and/or take part in the study.

研究者

相似试验